Shuyan Wei1, Charles Green2, Van Thi Thanh Truong2, John Howell3, Stephanie Martinez Ugarte3, Rondel Albarado4, Ethan A Taub4, David E Meyer4, Sasha D Adams4, Michelle K McNutt4, Laura J Moore4, Bryan A Cotton4, Lillian S Kao5, Charles E Wade4, John B Holcomb4, John A Harvin4. 1. Center for Translational Injury Research, McGovern Medical School at the University of Texas Health Science Center, Houston, TX, USA; Department of Surgery, McGovern Medical School at the University of Texas Health Science Center, Houston, TX, USA; Center for Surgical Trials and Evidence-based Practice, USA. Electronic address: shuyan.wei@uth.tmc.edu. 2. Department of Pediatrics, McGovern Medical School at the University of Texas Health Science Center, Houston, TX, USA; Center for Clinical Research and Evidence-based Medicine, USA. 3. Department of Surgery, McGovern Medical School at the University of Texas Health Science Center, Houston, TX, USA. 4. Center for Translational Injury Research, McGovern Medical School at the University of Texas Health Science Center, Houston, TX, USA; Department of Surgery, McGovern Medical School at the University of Texas Health Science Center, Houston, TX, USA. 5. Center for Translational Injury Research, McGovern Medical School at the University of Texas Health Science Center, Houston, TX, USA; Department of Surgery, McGovern Medical School at the University of Texas Health Science Center, Houston, TX, USA; Center for Surgical Trials and Evidence-based Practice, USA.
Abstract
INTRODUCTION: In 2013, we implemented a pill-based, multi-modal pain regimen (MMPR) in order to decrease in-hospital opioid exposure after injury at our trauma center. We hypothesized that the MMPR would decrease inpatient oral morphine milligram equivalents (MME), decrease opioid prescriptions at discharge, and result in similar Numerical Rating Scale (NRS) pain scores. METHODS: Adult patients admitted to a level-1 trauma center with ≥1 rib fracture from 2010 to 2017 were included - spanning 3 years before and 4 years after MMPR implementation. MME were summarized as medians and interquartile range (IQR) by year of admission. The effect of the MMPR on daily total MME was estimated using Bayesian generalized linear model. RESULTS: Over the 8 year study period, 6,933 patients who met study inclusion criteria were included. No significant differences between years were observed in Abbreviated Injury Scale (AIS) Chest or Injury Severity Scores (ISS). After introduction of the MMPR, there was a significant reduction in median total MME administered per patient day from 60 MME/patient day (IQR 36-91 MME/patient day) pre-MMPR implementation to 37 MME/patient day (IQR 18-61 MME/patient day) in 2017, p < 0.01. Total MME administered per patient day decreased by 31% in 2017 as compared to 2010 (rate ratio 0.69, 95% CI 0.64-0.75). Average NRS pain scores decreased by 0.8 points (95% CI -0.87, -0.81) from 2010 to 2017. CONCLUSION: The introduction of a multi-modal pain regimen resulted in significant reduction in in-patient opioid exposure after injury. The reduction in inpatient opioid use from 2010 to 2017 was equivalent to 11 mg less oxycodone or 17 mg less hydrocodone per patient per day. Additionally, use of the MMPR was associated with a reduction in NRS pain scores. Published by Elsevier Inc.
INTRODUCTION: In 2013, we implemented a pill-based, multi-modal pain regimen (MMPR) in order to decrease in-hospital opioid exposure after injury at our trauma center. We hypothesized that the MMPR would decrease inpatient oral morphine milligram equivalents (MME), decrease opioid prescriptions at discharge, and result in similar Numerical Rating Scale (NRS) pain scores. METHODS: Adult patients admitted to a level-1 trauma center with ≥1 rib fracture from 2010 to 2017 were included - spanning 3 years before and 4 years after MMPR implementation. MME were summarized as medians and interquartile range (IQR) by year of admission. The effect of the MMPR on daily total MME was estimated using Bayesian generalized linear model. RESULTS: Over the 8 year study period, 6,933 patients who met study inclusion criteria were included. No significant differences between years were observed in Abbreviated Injury Scale (AIS) Chest or Injury Severity Scores (ISS). After introduction of the MMPR, there was a significant reduction in median total MME administered per patient day from 60 MME/patient day (IQR 36-91 MME/patient day) pre-MMPR implementation to 37 MME/patient day (IQR 18-61 MME/patient day) in 2017, p < 0.01. Total MME administered per patient day decreased by 31% in 2017 as compared to 2010 (rate ratio 0.69, 95% CI 0.64-0.75). Average NRS pain scores decreased by 0.8 points (95% CI -0.87, -0.81) from 2010 to 2017. CONCLUSION: The introduction of a multi-modal pain regimen resulted in significant reduction in in-patient opioid exposure after injury. The reduction in inpatient opioid use from 2010 to 2017 was equivalent to 11 mg less oxycodone or 17 mg less hydrocodone per patient per day. Additionally, use of the MMPR was associated with a reduction in NRS pain scores. Published by Elsevier Inc.
Authors: Andrea M Trescot; Scott E Glaser; Hans Hansen; Ramsin Benyamin; Samir Patel; Laxmaiah Manchikanti Journal: Pain Physician Date: 2008-03 Impact factor: 4.965
Authors: Hawre Jalal; Jeanine M Buchanich; Mark S Roberts; Lauren C Balmert; Kun Zhang; Donald S Burke Journal: Science Date: 2018-09-21 Impact factor: 47.728
Authors: Peter M Grace; Keith A Strand; Erika L Galer; Daniel J Urban; Xiaohui Wang; Michael V Baratta; Timothy J Fabisiak; Nathan D Anderson; Kejun Cheng; Lisa I Greene; Debra Berkelhammer; Yingning Zhang; Amanda L Ellis; Hang Hubert Yin; Serge Campeau; Kenner C Rice; Bryan L Roth; Steven F Maier; Linda R Watkins Journal: Proc Natl Acad Sci U S A Date: 2016-05-31 Impact factor: 11.205
Authors: Howard N Bockbrader; David Wesche; Raymond Miller; Sunny Chapel; Nancy Janiczek; Paula Burger Journal: Clin Pharmacokinet Date: 2010-10 Impact factor: 6.447
Authors: Daniel J Cobaugh; Carl Gainor; Cynthia L Gaston; Tai C Kwong; Barbarajean Magnani; Mary Lynn McPherson; Jacob T Painter; Edward P Krenzelok Journal: Am J Health Syst Pharm Date: 2014-09-15 Impact factor: 2.637
Authors: John A Harvin; Charles E Green; Laura E Vincent; Kandice L Motley; Jeanette Podbielski; Charles C Miller; Jon E Tyson; John B Holcomb; Charles E Wade; Lillian S Kao Journal: Trauma Surg Acute Care Open Date: 2018-08-19
Authors: John A Harvin; Rondel Albarado; Van Thi Thanh Truong; Charles Green; Jon E Tyson; Claudia Pedroza; Charles E Wade; Lillian S Kao Journal: J Am Coll Surg Date: 2021-01-21 Impact factor: 6.113
Authors: Russell G Witt; Timothy E Newhook; Laura R Prakash; Morgan L Bruno; Elsa M Arvide; Whitney L Dewhurst; Naruhiko Ikoma; Jessica E Maxwell; Michael P Kim; Jeffrey E Lee; Matthew H G Katz; Ching-Wei D Tzeng Journal: J Surg Res Date: 2022-03-17 Impact factor: 2.417
Authors: Shakira W Burton; Christina Riojas; Gail Gesin; Charlotte B Smith; Vashti Bandy; Ronald Sing; Tamar Roomian; Meghan K Wally; Cynthia W Lauer Journal: J Trauma Acute Care Surg Date: 2022-03-01 Impact factor: 3.697
Authors: Gabrielle E Hatton; Heather R Kregel; Claudia Pedroza; Thaddeus J Puzio; Sasha D Adams; Charles E Wade; Lillian S Kao; John A Harvin Journal: Ann Surg Date: 2021-10-01 Impact factor: 13.787
Authors: Gabrielle E Hatton; Cynthia Bell; Shuyan Wei; Charles E Wade; Lillian S Kao; John A Harvin Journal: J Trauma Acute Care Surg Date: 2020-10 Impact factor: 3.697
Authors: John A Harvin; Van Thi Thanh Truong; Charles E Green; LaDonna Allen; Jason Murry; John J Radosevich; James N Bogert; Patrick B Murphy; Brandy B Padilla-Jones; Ben L Zarzaur; John R Taylor; Kevin W Sexton; Cassandra Decker; Thomas J Schroeppel; Charles E Wade; Lillian S Kao Journal: J Trauma Acute Care Surg Date: 2020-06 Impact factor: 3.697
Authors: Thaddeus J Puzio; James Klugh; Michael W Wandling; Charles Green; Julius Balogh; Samuel J Prater; Christopher T Stephens; Paulina B Sergot; Charles E Wade; Lillian S Kao; John A Harvin Journal: Trials Date: 2022-07-27 Impact factor: 2.728
Authors: Deepanjli Donthula; Christopher R Conner; Van Thi Thanh Truong; Charles Green; Chuantao Jiang; Michael W Wandling; Spogmai Komak; Todd F Huzar; Sasha D Adams; Daniel J Freet; David J Wainwright; Charles E Wade; Lillian S Kao; John A Harvin Journal: J Burn Care Res Date: 2021-11-24 Impact factor: 1.845